Swinging into full gear: Strengthening industry engagement in HIV vaccine research and development

Africa HIV cure research: Strengthening industry-community engagement in clinical researchПодробнее

What do we need an HIV vaccine when we have treatments and PrEP?Подробнее

Global HIV Vaccine Enterprise annual stakeholders meeting: Accelerating early phase vaccine researchПодробнее

Part 2: AIDS Vaccine Research and Development Efforts at NIAIDПодробнее

2022 HIV Cure meeting - Session 3Подробнее

Investment and Engagement in HIV Cure Research: Looking AheadПодробнее

2022 HIV Cure meeting - Session 4Подробнее

World-first gonorrhoea vaccine rollout begins in UKПодробнее

Lynn Morris - HIV prevention: antibodies and vaccine developmentПодробнее

W26052107 Gene signature associating with HIV vaccine efficacy and antibody effector functionПодробнее

VE Panel 1: Design approaches for current and future HIV prevention efficacy trialsПодробнее

W26052102 Imbokodo & Mosaico updates, plans for correlates and sieve analyses.Подробнее

HIVR4P // Virtual 2021 (SA16) How HIV Vaccine R&D is enabling the rapid COVID-19 vaccine responseПодробнее

HIV vaccine phasesПодробнее

Discussion | HIV/AIDS vaccine developmentПодробнее

The Fight Against HIV/AIDS | HIV vaccine developmentПодробнее

Advances in HIV Vaccines for Prevention and Treatment - Glenda E. Gray, MBBCH, FCPaeds (SA), DScПодробнее

Dan Barouch: Novel HIV Vaccine StrategiesПодробнее

Pathways to an HIV Vaccine - Mike keeferПодробнее